Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients

We evaluated a neutralizing anti-TGFβ antibody (GC1008) in cancer patients with malignant pleura mesothelioma (MPM). The goal of this study was to assess immunoregulatory effects in relation to clinical safety and clinical response. Patients with progressive MPM and 1–2 prior systemic therapies rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevenson, James P, Kindler, Hedy L, Papasavvas, Emmanouil, Sun, Jing, Jacobs-Small, Mona, Hull, Jennifer, Schwed, Daniel, Ranganathan, Anjana, Newick, Kheng, Heitjan, Daniel F, Langer, Corey J, McPherson, John M, Montaner, Luis J, Albelda, Steven M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812201/
https://www.ncbi.nlm.nih.gov/pubmed/24179709
http://dx.doi.org/10.4161/onci.26218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812201/
https://www.ncbi.nlm.nih.gov/pubmed/24179709
http://dx.doi.org/10.4161/onci.26218

Ejemplares similares